comparemela.com
  1. Home
  2. Live Updates
  3. Rosetrees Foundation - Breaking News

Rosetrees Foundation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19

In this randomised, double blind, 2x2 factorial placebo-controlled trial, Dr David Lowe and colleagues investigate the impact of early antiviral therapy in COVID-19.

United kingdomCity ofNorgen biotekUnited kingdom medical research councilRosetrees foundationTrial steering committeeUniversity of birminghamUniversity college london hospitalJohn black foundationNational health serviceWales research ethics committeeBristol myers squibbFujifilm toyama chemical coBritish society for antimicrobial chemotherapyData monitoring committeeGedeon richter

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.